BRISTOL REGIONAL MEDICAL CENTER
- Type
- Teaching hospital
- Where
- Bristol, TN
- Medicare CCN
- 440012
- Received
- $273,072 in 53 records, 2023 ($48,300 general, $224,772 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 34 | $48,300 |
| 2023 | Research payment | 19 | $224,772 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Contego Medical, Inc | 7 | $150,493 | 2023 |
| Incyte Corporation | 3 | $33,145 | 2023 |
| Medtronic, Inc. | 4 | $29,800 | 2023 |
| Genentech, Inc. | 6 | $27,114 | 2023 |
| Daiichi Sankyo Inc. | 2 | $12,873 | 2023 |
| Insulet Corporation | 13 | $11,400 | 2023 |
| Tandem Diabetes Care, Inc. | 16 | $6,400 | 2023 |
| Eli Lilly and Company | 1 | $1,146 | 2023 |
| Organon Llc | 1 | $700 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 19 | $224,772 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 31 | $47,100 |
| Long term medical supply or device loan | 1 | $700 |
| Space rental or facility fees (teaching hospital only) | 1 | $250 |
| Education | 1 | $250 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-12-27 | Incyte Corporation | $16,447 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2023 | |
| 2023-12-21 | Insulet Corporation | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-12-15 | Medtronic, Inc. | $13,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MINIMED 780G Device, Durable Pump | 2023 | |
| 2023-12-15 | Insulet Corporation | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-12-01 | Contego Medical, Inc | $22,593 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-11-30 | Insulet Corporation | $225 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-11-13 | Genentech, Inc. | $593 | Research payment | Cash or cash equivalent | Herceptin Biological, BioOncology | Chemo trastuzumab vs chemo trastuzumab pertuzumab | 2023 |
| 2023-11-10 | Insulet Corporation | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-11-01 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-10-26 | Insulet Corporation | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-10-05 | Insulet Corporation | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-10-04 | Incyte Corporation | $250 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2023 | |
| 2023-09-28 | Medtronic, Inc. | $12,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MINIMED 780G Device, Durable Pump | 2023 | |
| 2023-09-20 | Tandem Diabetes Care, Inc. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-09-05 | Insulet Corporation | $3,075 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-08-25 | Insulet Corporation | $1,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-08-18 | Contego Medical, Inc | $27,437 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-08-16 | Genentech, Inc. | $7,448 | Research payment | Cash or cash equivalent | Tecentriq Biological, BioOncology | Phase III study in Adjuvant therapy in Renal Cell Carcinoma patients | 2023 |
| 2023-08-08 | Genentech, Inc. | $1,000 | Research payment | Cash or cash equivalent | PH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC | 2023 | |
| 2023-08-01 | Eli Lilly and Company | $1,146 | Research payment | Cash or cash equivalent | A RANDOMIZED OPEN-LABEL PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD A | 2023 | |
| 2023-07-26 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-07-20 | Daiichi Sankyo Inc. | $8,067 | Research payment | Cash or cash equivalent | DS8201-A-U305 | 2023 | |
| 2023-07-20 | Insulet Corporation | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-07-19 | Genentech, Inc. | $1,972 | Research payment | Cash or cash equivalent | Herceptin Biological, BioOncology | Chemo trastuzumab vs chemo trastuzumab pertuzumab | 2023 |
| 2023-07-19 | Tandem Diabetes Care, Inc. | $550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-06-26 | Medtronic, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MINIMED 770G Device, Durable Pump | 2023 | |
| 2023-06-23 | Contego Medical, Inc | $32,343 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-06-23 | Organon Llc | $700 | Long term medical supply or device loan | In-kind items and services | JADA SYSTEM Device, POSTPARTUM UTERINE HEMORRHAGING | 2023 | |
| 2023-06-15 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-06-08 | Insulet Corporation | $225 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-06-07 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-06-06 | Genentech, Inc. | $1,500 | Research payment | Cash or cash equivalent | PH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC | 2023 | |
| 2023-05-25 | Contego Medical, Inc | $4,000 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-05-18 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-05-03 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-05-03 | Insulet Corporation | $250 | Education | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-05-03 | Insulet Corporation | $225 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-04-19 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-04-13 | Contego Medical, Inc | $11,400 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-04-12 | Genentech, Inc. | $14,600 | Research payment | Cash or cash equivalent | Tecentriq Biological, BioOncology | Atezo or Pembro plus chemo with or without Tiragolumab in 1L NSCLC SKYSCRAPER 06 | 2023 |
| 2023-04-12 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-03-27 | Medtronic, Inc. | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MINIMED 770G Device, Durable Pump | 2023 | |
| 2023-03-23 | Contego Medical, Inc | $1,350 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-03-23 | Tandem Diabetes Care, Inc. | $250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-03-15 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-03-13 | Daiichi Sankyo Inc. | $4,805 | Research payment | Cash or cash equivalent | DS8201-A-U305 | 2023 | |
| 2023-03-09 | Incyte Corporation | $16,447 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2023 | |
| 2023-03-08 | Tandem Diabetes Care, Inc. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-02-23 | Contego Medical, Inc | $51,368 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2023 |
| 2023-02-01 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-01-25 | Tandem Diabetes Care, Inc. | $1,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 | |
| 2023-01-20 | Insulet Corporation | $1,425 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2023 | |
| 2023-01-05 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bristol, TN, county Sullivan County, TN, state Tennessee; placed by its city name.
| Measure | Place (city or town) Bristol, TN | County Sullivan County, TN | State Tennessee |
|---|---|---|---|
| Population B01003 | 27,636 | 160,624 | 7,066,383 |
| Population, 2020 census P1 | 27,147 | 158,163 | 6,910,840 |
| Median age B01002 | 41.1 | 45.0 | 38.9 |
| Under 18 B01001 | 20.2% | 19.1% | 22.2% |
| 65 and over B01001 | 19.5% | 22.2% | 17.1% |
| Households B11001 | 12,119 | 68,907 | 2,824,277 |
| Foreign born B05002 | 1.8% | 1.9% | 6.1% |
| Median household income B19013 | $58,162 | $58,807 | $69,595 |
| Median family income B19113 | $74,271 | $78,264 | $87,314 |
| Per capita income B19301 | $36,687 | $35,877 | $39,437 |
| Poverty rate B17001 | 13.6% | 15.4% | 13.8% |
| Unemployment rate B23025 | 6.8% | 5.4% | 4.7% |
| Civilian labor force B23025 | 13,911 | 75,119 | 3,527,571 |
| Mean commute (minutes) B08013 | 21.2 | 21.9 | 25.7 |
| Bachelor's degree or higher B15003 | 30.6% | 26.8% | 31.1% |
| Housing units B25001 | 13,263 | 76,324 | 3,143,670 |
| Owner-occupied B25003 | 67.4% | 72.1% | 66.9% |
| Renters B25003 | 32.6% | 27.9% | 33.1% |
| Median home value B25077 | $194,500 | $213,300 | $286,700 |
| Median gross rent B25064 | $842 | $889 | $1,189 |
| White, not Hispanic B03002 | 89.5% | 91.6% | 71.0% |
| Black B03002 | 3.1% | 2.0% | 15.4% |
| Hispanic or Latino B03002 | 3.3% | 2.6% | 7.4% |
| Asian B03002 | 0.3% | 0.7% | 1.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bristol, TN.
Comments